Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EDNRA | P25101 | 12/20 | 0.81 |
| ▸ | EDNRB | P24530 | 10/20 | 0.81 |
| ▸ | AGTR1 | P30556 | 3/20 | 0.62 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8124977 | 0.92 | EDNRA (0.81) | EDNRAEDNRBAGTR1AGTR2 | |
| SCHEMBL8904132 | 0.90 | EDNRA (0.78) | EDNRAEDNRBAGTR1AGTR2 | |
| SCHEMBL8903482 | 0.90 | EDNRA (0.83) | EDNRAEDNRBAGTR1AGTR2 | |
| SCHEMBL7333006 | 0.89 | EDNRA (0.79) | EDNRAEDNRBAGTR1AGTR2 | |
| SCHEMBL7332944 | 0.89 | EDNRA (0.88) | EDNRAEDNRBAGTR1AGTR2 | |
| L-754142 SCHEMBL29551244 | 0.89 | EDNRA (1.00) | EDNRAEDNRBAGTR1AGTR2 | |
| L-754142 SCHEMBL4193035 | 0.89 | EDNRA (1.00) | EDNRAEDNRBAGTR1AGTR2 | |
| SCHEMBL795556 | 0.89 | EDNRA (0.79) | EDNRAEDNRBAGTR1AGTR2 | |
| L-754142 SCHEMBL7722258 | 0.89 | EDNRA (0.98) | EDNRAEDNRBAGTR1AGTR2 | |
| SCHEMBL7329183 | 0.89 | EDNRA (0.86) | EDNRAEDNRBAGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5668176-A | ENDOTHELIN ANTAGONIST | MERCK & CO. INC. (US) | 1997-09-16 | — | — | US | disclosed |
| US-5565485-A | TREATING CARDIOVASCULAR DISORDERS | MERCK & CO., INC. (US) | 1996-10-15 | — | — | US | disclosed |
| WO-1996009818-A1 | ENDOTHELIN RECEPTOR ANTAGONISTS FOR THE TREATMENT OF EMESIS | MERCK & CO., INC. (US) | 1996-04-04 | — | — | WO | disclosed |